Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial

Journal of the American Medical Association

Volumn 286, Issue 17, 2001, Pages 2099-2106

  Orringer, Eugene P ^a   Ataga, Kenneth I ^a   Casella, James F ^b   Koshy, Mabel ^c   Adams Graves, Patricia ^d   Luchtman Jones, Lori ^e   Wun, Ted ^f   Watanabe, Masayo ^g   Shafer, Frank ^h   Kutlar, Abdullah ⁱ   Abboud, Miguel ^j   Steinberg, Martin ^k   Adler, Brian ^l   Swerdlow, Paul ^m   Terregino, Carol ⁿ   Saccente, Suzanne ^o   Files, Beatrice ^p   Ballas, Samir ^q   Wojtowicz Praga, Slawomir ^r   Grindel, J Michael ^s   Brown, Samir ^t   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^e ST LOUIS CHILDREN S HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g CHILDREN S MERCY HOSPITAL   (United States)

^h ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

ⁱ MEDICAL COLLEGE OF GEORGIA   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^l UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^m HARPER UNIVERSITY HOSPITAL   (United States)

ⁿ ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^o Arkansas Children s Hospital   (United States)

^p EAST CAROLINA UNIVERSITY   (United States)

^q THOMAS JEFFERSON UNIVERSITY   (United States)

^r Theradex   (United States)

^s CytRx Corporation   (United States)

^t Independent statistician   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CODEINE; DIHYDROMORPHINE; HYDROXYUREA; MORPHINE; NARCOTIC AGENT; OXYCODONE; PARACETAMOL; PETHIDINE; PLACEBO; POLOXAMER;

ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; FAT EMBOLISM; FEMALE; FLUID THERAPY; HOSPITALIZATION; HUMAN; INFLAMMATION; INFUSION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; OXYGEN THERAPY; PAIN; PAIN ASSESSMENT; PHARMACOECONOMICS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; STATISTICAL ANALYSIS; TISSUE OXYGENATION; VALIDATION PROCESS;

EID: 0035824175     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.17.2099     Document Type: Article

References (39)

1. The acute painful episode
2. Erythrocyte adherence to endothelium in sickle cell anemia: A possible determinant of disease severity
3. + sickle reticulocytes to endothelial cells
4. Unusually large von Willebrand factor multimers preferentially promote young sickle and non-sickle erythrocyte adhesion to endothelial cells
5. α4β1-Integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium
6. Sickle reticulocytes adhere to VCAM-1
7. Integrin α4β1 and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia
8. Effects of poloxamer 188 on the assembly, structure and dissolution of fibrin clots
9. Haemorheological effects of a nonionic copolymer surfactant (poloxamer 188)
10. Pluronic F-68 reduces the endothelial adherence and improves the rheology of liganded sickle erythrocytes
11. Microcirculatory effects of blocking cell adhesion molecules in transgenic sickle cell mice
12. The effects of RheothRx on platelet function and coagulation in man
13. A nonionic surfactant and blood viscosity
14. The effect of RheothRx injection on the hemorheological parameters in patients with acute myocardial infarction
15. Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx injection)
16. RheothRx (poloxamer 188) injection for the acute painful episode of sickle cell disease: A pilot study
17. Multicenter trial of FLOCOR in patients with sickle cell disease and acute chest syndrome
18. Phase I study of FLOCOR in patients with acute chest syndrome of sickle cell disease
19. A phase III, multicenter, randomized, double-blind, placebo-controlled study of FLOCOR (purified poloxamer 188) in patients with sickle cell disease in acute vaso-occlusive crisis
20. Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain: Comparison in patients in the emergency department
21. Pain measurement in hospitalized adults with sickle cell painful episodes
22. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis
23. Designs for group sequential tests
24. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial
25. Hydroxyurea effects on hemoglobin F production in patients with sickle cell anemia
26. Effects of hydroxyurea on the rheological properties of sickle erythrocytes in vivo
27. Multicenter study of hydroxyurea in sickle cell anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
28. Bone marrow transplantation for sickle cell disease
29. Bone marrow transplantation in sickle cell anemia - The dilemma of choice
30. A collaborative, double-blind, randomized study of cetiedil citrate in sickle cell crisis
31. Clinical trials of therapy for sickle cell vaso-occlusive crises
32. Clinical evaluation of cyanate in sickle cell anemia
33. Sodium cyanate induced polyneuropathy in patients with sickle cell disease
34. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease